| 000 | 01384 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511195809.0 | ||
| 264 | 0 | _c19911129 | |
| 008 | 199111s 0 0 eng d | ||
| 022 | _a0098-7484 | ||
| 024 | 7 |
_a10.1001/jama.266.18.2605 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeterson, H B | |
| 245 | 0 | 0 |
_aPelvic inflammatory disease. Key treatment issues and options. _h[electronic resource] |
| 260 |
_bJAMA _cNov 1991 |
||
| 300 |
_a2605-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnti-Bacterial Agents |
| 650 | 0 | 4 | _aCenters for Disease Control and Prevention, U.S. |
| 650 | 0 | 4 |
_aChlamydia Infections _xdrug therapy |
| 650 | 0 | 4 | _aChlamydia trachomatis |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGonorrhea _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPelvic Inflammatory Disease _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aWalker, C K | |
| 700 | 1 | _aKahn, J G | |
| 700 | 1 | _aWashington, A E | |
| 700 | 1 | _aEschenbach, D A | |
| 700 | 1 | _aFaro, S | |
| 773 | 0 |
_tJAMA _gvol. 266 _gno. 18 _gp. 2605-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.266.18.2605 _zAvailable from publisher's website |
| 999 |
_c1664881 _d1664881 |
||